CIENCIASMEDICASNEWS: Next Generation BLI: Gator Bio Label-Free Analysis

viernes, 18 de septiembre de 2020

Next Generation BLI: Gator Bio Label-Free Analysis

	Antibodies
	The latest antibodies news from News Medical

VHH Antibodies (Nanobodies) Advantages and Limitations

Next Generation BLI: Gator Bio Label-Free Analysis

Gator Bio offers solutions to researchers. Our next generation BLI (biolayer interferometry) technology enables the label-free measurement of biomolecules in a wide range of applications. From rapid quantitation of crude or purified samples to affinity determination of mM to pM interactions, Gator BLI can help improve your research and development.

Find Out More

Discover Simoa® Ultra-Sensitive Cytokine Detection to Move COVID-19

Recent evidence suggests cytokine imbalances may fail to clear SARS-CoV-2 infection and induce protection against reinfection. With Simoa SP-X, measuring cytokines at 10-100x lower levels enables robust quantification of healthy baselines and early rises of cytokines in order to:

Identify predictive biomarkers of disease severity
Monitor disease progression
Determine Th1/Th2 balance
Evaluate therapeutic impacts on inflammatory response
Quantify low abundance cytokines
Quantify medium- to high-abundance cytokines in low and highly diluted sample volumes

Learn More

Using Antibodies in Immune Deficiency Treatment

Antibodies or immunoglobulins can be used in the treatment of immune deficiency disorders.

	Study pinpoints specific protein involved in the mass production of antibodies A team of researchers has discovered how a specific protein called JAGN1 plays a crucial role in the production of antibodies.

	Candidate monoclonal antibody shows hope as COVID-19 treatment Researchers in the United States have described the effectiveness of a candidate monoclonal antibody currently being evaluated in a Phase 1 trial as a therapy for coronavirus disease 2019 (COVID-19) and its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

	Antibody profile differentiates non-celiac gluten sensitivity from celiac disease A new study of the antibodies produced by people with gluten sensitivity may lead to a better way to detect the condition and treat it.